Lindbrook Capital, LLC - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 93 filers reported holding UROGEN PHARMA LTD in Q3 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2021$9,000
+200.0%
513
+198.3%
0.00%
+100.0%
Q2 2021$3,000
-40.0%
172
-38.1%
0.00%0.0%
Q1 2021$5,000
-16.7%
278
-21.9%
0.00%0.0%
Q4 2020$6,000
-14.3%
356
-3.5%
0.00%
-50.0%
Q3 2020$7,000
-46.2%
369
-24.7%
0.00%
-50.0%
Q2 2020$13,000
+225.0%
490
+146.2%
0.00%
+100.0%
Q1 2020$4,000
-55.6%
199
-26.3%
0.00%
-33.3%
Q4 2019$9,0002700.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q3 2021
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,111,050$9,099,0004.23%
GREAT POINT PARTNERS LLC 873,424$7,153,0001.72%
Wildcat Capital Management, LLC 533,139$4,366,0001.45%
Opaleye Management Inc. 238,670$1,955,0000.88%
MENORA MIVTACHIM HOLDINGS LTD. 2,949,489$24,156,0000.44%
Annandale Capital, LLC 84,331$691,0000.27%
Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. 25,330$206,0000.18%
RTW INVESTMENTS, LP 857,464$7,023,0000.18%
Harel Insurance Investments & Financial Services Ltd. 1,025,611$8,400,0000.18%
BENDER ROBERT & ASSOCIATES 41,131$337,0000.13%
View complete list of UROGEN PHARMA LTD shareholders